{"schema_version":"secwatch.filing_event.v1","accession":"0001472375-24-000106","form_type":"8-K","ticker":"RGPX","cik":"0001357878","company_name":"REGENEREX PHARMA, INC.","filed_at":"2024-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.249571+00:00","generated_at":"2026-05-29T05:06:59.727547+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"RegeneRx Pharma announces CFO resignation and appointments of new CFO, Secretary, and board member","bullets":["Deborah Pilant resigned as CFO, Secretary/Treasurer, and board director effective Dec 6, 2024, due to retirement.","Brent Wilson appointed CFO; CPA with 30 years experience, previously at KPMG, effective Dec 6, 2024.","Dr. Lee Ori appointed Secretary/Treasurer for the coming year; currently serves as a board director.","J. Kenneth Hazen appointed to the board; President/CEO of CTSI-Global, recognized in logistics and supply chain."],"urls":{"canonical":"https://secwatch.observer/filing/0001472375-24-000106","json":"https://secwatch.observer/filing/0001472375-24-000106.json","markdown":"https://secwatch.observer/filing/0001472375-24-000106.md","text":"https://secwatch.observer/filing/0001472375-24-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357878/000147237524000106/0001472375-24-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357878/000147237524000106/ixform8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T05:06:59.727547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}